With a Ph.D. in Neuroscience Olga has held a number of roles in clinical trials management, drug development, biotech and pharmaceutics. As a trained neuropharmacologist and a registered pharmacist Dr. Chernoloz, head of Omnica Biotech, helps cannabinoid space players of all sizes to guide R&D programs, run feasibility analyses and optimize business development strategy taking into consideration scientific and regulatory underpinnings. The research program for development of cannabinoid veterinary drugs developed by her company was since adopted and successfully run through clinical trials.
Dr. Chernoloz has developed and delivered educational modules for medical and adult cannabis space in both academic and business settings. Olga has designed and delivered a course in one of the first cannabis-centric college programs at AAPS and is leading the Science of Cannabis course at the Ryerson University .
Looking to share her knowledge and experience Olga mentors participants of cannabis startup accelerator Leaf Forward. Dr. Chernoloz provides scientific advisory to companies in cannabinoid space.
Prior to pivoting into cannabinoid field Olga specialized in mental health research authoring number of original research articles and a chapter in an instructional book on Neurobiology of Mood Disorders.
